Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer

Kerri Beckmann; Hans Garmo; Jan Adolfsson; Cecilia Bosco; Eva Johansson; David Robinson; Lars Holmberg; P Stattin; Mieke Van Hemelrijck

doi:10.1016/j.eururo.2018.11.022

Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer

Kerri Beckmann, Hans Garmo, Jan Adolfsson, Cecilia Bosco, Eva Johansson, David Robinson, Lars Holmberg, P Stattin, Mieke Van Hemelrijck

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

242 Downloads (Pure)

Original language	English
Journal	European Urology
Early online date	26 Nov 2018
DOIs	https://doi.org/10.1016/j.eururo.2018.11.022
Publication status	E-pub ahead of print - 26 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2018.11.022

Androgen deprivation therapies and_BECKMANN_Accepted8November2018_GREEN AAMAccepted author manuscript, 228 KB

Cite this

Beckmann, K., Garmo, H., Adolfsson, J., Bosco, C., Johansson, E., Robinson, D., Holmberg, L., Stattin, P., & Van Hemelrijck, M. (2018). Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer. European Urology. Advance online publication. https://doi.org/10.1016/j.eururo.2018.11.022

@article{07af9fbe7d124091b51dc505a5410c76,

title = "Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer",

author = "Kerri Beckmann and Hans Garmo and Jan Adolfsson and Cecilia Bosco and Eva Johansson and David Robinson and Lars Holmberg and P Stattin and {Van Hemelrijck}, Mieke",

year = "2018",

month = nov,

day = "26",

doi = "10.1016/j.eururo.2018.11.022",

language = "English",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

}

Beckmann, K , Garmo, H, Adolfsson, J, Bosco, C, Johansson, E, Robinson, D, Holmberg, L, Stattin, P & Van Hemelrijck, M 2018, 'Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer', European Urology. https://doi.org/10.1016/j.eururo.2018.11.022

TY - JOUR

T1 - Androgen deprivation therapies and changes in comorbidity

T2 - A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer

AU - Beckmann, Kerri

AU - Garmo, Hans

AU - Adolfsson, Jan

AU - Bosco, Cecilia

AU - Johansson, Eva

AU - Robinson, David

AU - Holmberg, Lars

AU - Stattin, P

AU - Van Hemelrijck, Mieke

PY - 2018/11/26

Y1 - 2018/11/26

U2 - 10.1016/j.eururo.2018.11.022

DO - 10.1016/j.eururo.2018.11.022

M3 - Article

SN - 0302-2838

JO - European Urology

JF - European Urology

ER -

Androgen deprivation therapies and changes in comorbidity: A Comparison of gonadotropin releasing hormone agonists and anti-androgen monotherapy as primary therapy in men with high risk prostate cancer

UN SDGs

Access to Document

Other files and links

Cite this